Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MC Access
Rockville, Maryland, United Statesmontgomerycollege.edu ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Access Pharmaceuticals developed proprietary drug delivery technologies leveraging vitamin B12 pathways to improve oral bioavailability of drugs traditionally administered by injection. Their lead assets included MuGard™ (FDA-cleared oral rinse for mucositis), ProLindac™ (DACH platinum prodrug in Phase II trials), Thiarabine™ (nucleoside analog with preclinical/early clinical activity), and advanced nanoparticle/oral formulations targeting oncology and metabolic diseases. Clinical results showed promise particularly with improved tolerability or novel administration routes but no recent updates confirm ongoing development or commercialization beyond early 2010s.
- Therapeutic areas
- OncologyEndocrinologyDermatologyGastroenterologyCardiovascularNeurology
- Modalities
- Small moleculeNanoparticleNucleoside analogsDrug delivery technology (Cobalamin-mediated, vitamin B12-based)
- Industry
- Biotech
02
Partnerships
Multiple licensing/development agreements with major biotech/pharma companies focused on oral formulation development using proprietary technologies
Beyond the preview
Go deeper on MC Access.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MC Access.